Development and production of enzymes, microorganisms and biopharmaceutical ingredients for more than 30 industries
Novozymes A/S (Teil der Novonesis Group)
Bagsværd (DK) · Copenhagen (DK) · Franklinton (US) · Araucária (BR)New on Amplifa
About Novozymes
Novozymes A/S is a Danish biotechnology company headquartered in Bagsværd near Copenhagen. Founded in 2000 as a spin-off from Novo Nordisk, the company researches, develops and produces industrial enzymes, microorganisms and biopharmaceutical ingredients. The products are used in industries such as agriculture, food, detergents, bioenergy, animal nutrition and pharma, enabling, among other things, higher crop yields, low-temperature washing, energy-efficient production and renewable fuels. In January 2024, Novozymes merged with Chr. Hansen to form the Novonesis Group; the legal entity Novozymes A/S is part of this group. The company supplies around 130 markets worldwide and generated revenue of DKK 17.6 billion in 2022. Its roots go back to 1925, when the brothers Harald and Thorvald Pedersen founded the Novo Terapeutisk Laboratorium.
- Site
- Bagsværd
- Processes
- Development and production of enzymes, microorganisms and biopharmaceutical ingredients, Enzymatic, microbial and protein-based biosolutions for 30+ industries
- Materials
- Industrial Enzymes, Microorganisms, Protein-based Solutions
- Founded
- 2000 (Novo
- Employees
- approx. 10,000
- Industries
- Biotechnology, Agriculture, Food, Detergents, Bioenergy/Biofuels, Animal Nutrition
- 01
Research and development
- 02
Fermentation/bioproduction
- 03
Recovery and formulation
- 04
Distribution in over 130 markets
Product Groups and Biotechnologies
Industrial Enzymes
Enzymatic solutions for, among others, detergents, food, bioenergy and agriculture.
Microorganisms
Microbial solutions and probiotics for numerous industrial applications.
Protein-based Solutions
Advanced protein solutions for industrial and pharmaceutical-related applications.
Locations
Bagsværd
DKHeadquarters
- Materials
- Enzymes, Microorganisms
Copenhagen
DKLocation
Franklinton
USLocation
Araucária
BRLocation
Products
Inside the production
Industries
Additional services
History
- 1925
Brothers Harald and Thorvald Pedersen found Novo Terapeutisk Laboratorium and Nordisk Insulinlaboratorium
- 1941
Introduction of the first enzyme (trypsin for leather processing)
- 2000
Novozymes is created as a spin-off from Novo Nordisk
- 2016
Spin-off of the biopharma activities as Albumedix
- 2020
Acquisitions of PrecisionBiotics (USD 90 million) and Microbiome Labs (USD 125 million)
- 2022
Agreement to merge with Chr. Hansen (December)
- 2024
Merger with Chr. Hansen completed on 29.01. – Novonesis is formed
- 2024/25
Novonesis acquires MicroBioGen and the animal feed enzyme business of dsm-firmenich